Genome as a platform: Advancing MRD research with Illumina whole-genome sequencing oncology prep

Name: Genome as a platform: Advancing MRD research with Illumina whole-genome sequencing oncology prep
Start: 2026-11-11T12:00:00
End: 2026-11-11T12:50:00
Location: Seattle Convention Center (SCC)

Starts: November 11, 2026 at 12:00 PM
Ends: November 11, 2026 at 12:50 PM
Format: In person
Location: Seattle Convention Center (SCC), 900 Pine Street, Seattle, WA 98101

About This Event

Whole-genome sequencing (WGS) is redefining molecular residual disease (MRD) research by enabling comprehensive genomic characterization from a single platform. This workshop will introduce Illumina Whole-Genome Sequencing Oncology Prep, the first distributed whole-genome sequencing solution designed for highly sensitive MRD research and explore how laboratories can leverage WGS to support flexible, tailored MRD workflows. We will present initial evaluation data from this novel research assay, highlighting analytical performance, operational simplicity, enhanced molecular counting, and the sensitivity enabled by genome-wide interrogation. Attendees will gain insight into how WGS serves as a scalable foundation for the next generation of precision oncology research.